Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia.
Forghieri
Fabio
F
Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Azienda Ospedaliera-Universitaria Policlinico, Modena, Italy.
Rossi
Giulio
G
Potenza
Leonardo
L
Morselli
Monica
M
Barozzi
Patrizia
P
Vallerini
Daniela
D
Messino
Massimino
M
Rumpianesi
Fabio
F
Pecorari
Monica
M
Torelli
Giuseppe
G
Luppi
Mario
M
D000208:Acute Disease; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D001230:Aspergillus / Q000302:isolation & purification* / Q000648:ultrastructure; D000077336:Caspofungin; D003131:Combined Modality Therapy; D054714:Echinocandins / Q000627:therapeutic use; D006801:Humans; D025301:Hyphae / Q000648:ultrastructure*; D016867:Immunocompromised Host; D055744:Invasive Pulmonary Aspergillosis / Q000150:complications / Q000175:diagnosis; D015448:Leukemia, B-Cell / Q000150:complications* / Q000188:drug therapy; D055666:Lipopeptides; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000150:complications; D013154:Spleen / Q000382:microbiology* / Q000648:ultrastructure; D013156:Splenectomy; D013158:Splenic Diseases / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology / Q000473:pathology / Q000601:surgery; D014230:Triazoles / Q000627:therapeutic use
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D014230:Triazoles; C068538:liposomal amphotericin B; C101425:posaconazole; D000666:Amphotericin B; D000077336:Caspofungin